Roidipedia.Compound reference & reporting
05 AUG 2026
CompoundsResearch chemical Diclazepam
Research chemicalDepressantDesigner benzodiazepineGABAergic

Diclazepam

Also known as Chlorodiazepam · 2'-chloro-diazepam · Ro5-3448

Diclazepam (chlorodiazepam) is a designer benzodiazepine and a chlorine analogue of diazepam. It is long-acting, high-potency, and sold as a research chemical with no clinical development. Effects mirror classic benzodiazepines: anxiolysis, sedation, muscle relaxation and amnesia, with a correspondingly high potential for dependence and dangerous additive respiratory depression when combined with opioids or alcohol.

01 Overview

Diclazepam emerged on grey-market research-chemical vendors around 2013 as a legal substitute for scheduled benzodiazepines. It has never undergone human clinical trials; what is known comes from analytical chemistry, a small number of self-experiment reports, and forensic case reports involving intoxication and driving impairment.

Its long half-life and active metabolites (including delorazepam, lorazepam and lormetazepam) mean effects and impairment can persist far longer than users expect, and inter-dose accumulation is common. Because milligram doses are active, accurate dosing without laboratory equipment is difficult and a frequent cause of unintentional overdose when combined with other CNS depressants.

02 Mechanism

Positive allosteric modulator of the GABA-A receptor at the benzodiazepine site, increasing chloride conductance and enhancing inhibitory neurotransmission. Several metabolites are themselves active benzodiazepines, prolonging the effect.

03 Dosing

TierDoseRouteNotes
Threshold0.5–1 mgOralOnset is slow; redosing before peak is a common cause of overdose.
Common1–2 mgOralRoughly ten times the potency of diazepam by weight.
Strong2–3 mgOralHeavy sedation and marked next-day impairment; accumulation with repeat dosing.

04 Effects

EffectMagnitudeEvidence
AnxiolysisReduction in anxiety and psychological tension, as with other benzodiazepines.markedAnecdotal
Sedation and muscle relaxationDrowsiness, reduced muscle tone and impaired coordination.dose-dependentAnecdotal
Anterograde amnesiaImpaired formation of new memories during intoxication.common at higher dosesAnecdotal

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Physical dependence and withdrawalRegular use produces tolerance and dependence; abrupt cessation can cause rebound anxiety, insomnia, and seizures.SevereCommon with regular useObservational
Additive respiratory depressionCombining with opioids or alcohol can suppress breathing to a fatal degree.Life-threateningUncommon but potentially fatalObservational
Prolonged impairmentLong half-life and active metabolites cause next-day sedation, impaired driving and accumulation.ModerateCommonObservational

07 References

Diclazepam: a designer benzodiazepine — analytical and pharmacological reviewDrug Testing and Analysis, 2016
Designer benzodiazepines: a review of published dataEuropean Monitoring Centre for Drugs and Drug Addiction (EUDA)

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.